A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
for Obstructive Cardiomyopathy, Hypertrophic
Drug: Sotagliflozin
33 locations incl. Phoenix
Sponsor: Lexicon Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06481891·Phase 3·Recruiting